Thursday, May 20, 2010
In a brief scenario, an enterprises resources, processes and technology are aligned so as to support and proceed ahead as part of commercial operations that further helps in improvising innovations and create its effectiveness in the market places. It can be the role of the enterprises that makes them move into the market or for the market, keeping its hold over the competitive processes.
Lets explore more in detail regarding these commercial operations and more likely in relation to a pharmaceutical and life sciences industry, that has evolved in these processes over the past fifty years and has built up its sales activities and refined its marketing principles all over with a target towards the primary care physicians and delivering and selling best products.
Processes defined such as Commercial Operations Management keeps their hold across product innovations as well as marketing team, that makes it more accountable for their commercial and financial outcome. Here seems to be an integration process of two functional areas giving a clarity for enterprises that is always important and accountable for major decisions, designing and redesign processes and further relating all these towards a more measurable outcomes and further improvise processes.
Still to an extension of this, the commercial operations of a pharmaceutical enterprise are at the need of changing themselves and get optimized. Consumption of an enterprises revenue to an extent of 20-25 percent by these operations and still not facing effective results continuously has lead to the need to optimize and shift their operations from restricting sales representative access to physicians and also make a strategic approach after shifting towards the consumer advertising from direct operations. Also to work around with payers in ratcheting low prices.
Stating all of the above scenarios, it gives a clarity of all the aspects at which any pharmaceuticals commercial operations need to be changed and also we observe that they are being optimized like those of the products from the pharmaceutical pipelines, in a higher order are the special ones which are related to the smaller patient groups and specialists.
And despite the fact, these products accede, much more in their potentiality, to decrease morbidity and transience, they will also come to market pricing much more per course of remedy. This will emphasize the pressures between pharmaceutical commercial operations at one end and payers and providers over the other edge. To strongly succeed, any pharmaceutical enterprise's commercial operations must reach ahead of the process that just try to establish a value for the industry and maintain a situation of seeking so as to provide value to payers, providers and patients.
Wednesday, May 19, 2010
Seems to be stated as simple as such but if glanced through,there raises a point of fact definitely that one need to meet the regular challenges of government cost control in the process of drug manufacturing and various other processing and work around with rigorous regulations. Having met with such requisites, there raises an exact need to outsource the processes without drawbacks in the areas of quality or compliance efforts. More demandingly an effective decision making is what that comes into focus at this level with real-time traceability and statutory compliance in a pharmaceutical enterprise.
Decision making, without a pause, is emerging as an effective factor and comes into focus in any pharmaceutical enterprises wherein it plays a key role in the process of system automation, providing enterprise solutions that enables corporate, financial, process control, production planning that has effective decision making in place and have its lab operations and supply-chain decisions to be all synchronized and meet the process requirements in time.
Filling up the stop gaps that exist between the management sectors like those of operations and enterprise management systems, one can definitely achieve integrations for sure that are among the control applications with the on going transactional scenarios of sales, accounting vendor ratings, laboratory systems and many others. Decision making is what that makes it possible to achieve all of these at various levels.
Global widespread of pharmaceutical enterprises across their operations and market outlook enforces them to deal with competition with the global competitors. Effective decision making is the right process that is applicable in these scenarios which further leads to establishing collaborative relationships among various domains and its manufacturers. It leads to a collaborative approach among the regulatory industries like those of life sciences and pharmaceuticals.
Pharmaceutical enterprises are the key addressing areas when considering an infrastructure to support collaborative manufacturing management, and in turn go ahead with proper decision making that supports connectivity within the enterprise among various functional departments.
Information technology systems also tend to slow down the processes of approving and adopting the available new technologies which ensures real collaborative advantages, for example like those of Enterprise Resource Planning applications and advanced production management applications. Therefore, pharmaceutical enterprises have their continuous focus over effective decision making towards a proactive position with regard to their aging IT systems and move ahead. Lets have a more detailed insight in these lines in the later articles from our research desk.
Seems to be fine with the overview of data warehousing, but moving ahead in a different lines, lets explore how this is related to any other industry in the present global market, likely towards a pharmaceutical industry and more ahead at an enterprise level..
Taking an insight into a pharmaceutical industry definitely gives an impression that it is well indulged in the process of having large volumes of data that are related to the existing records, production of new results, fact based reports and many figures. As the process is continuous, data generation is never ending and may lead to a possibility of data overload, that raises a general question at ones mind regarding what to do with the huge volumes of data and what limitations can be applied towards processing the meaningful and actionable data.
Data warehousing comes into the point of focus of the industry that meets the needs of the pharmaceutical enterprises so as to control and access the data. It makes a clear affirmation that an approach of the pharmaceutical enterprises towards implementing a data warehouse makes the data or information available to a broad set of audience and definitely ensures proper decision support with relevant data and avoids any associated risks.
The definition of a data warehouse varies from one enterprise to another as they are defined accordingly with respect to the role they play in the enterprises which varies across like those of a data marts, data repositories and also as data warehouses.
Easy to create and less expensive data repositories have their role as a storage systems that accumulates huge amount of data. Over the other hand it lacks its ability to allow data manipulations that raises up the needs to transform data into meaningful information so as to project its actual and true value in the pharmaceutical enterprises.
This lead to the evolution of having a data warehouses in the pharmaceutical enterprises that over the other edge, has the capability to play the key roles of both a data repository and also as a data marts held within them. Data marts when designed specifically with a particular operational goal, meets the needs of the clinical programs.
Data warehouses would definitely exist all over in the pharmaceutical industry in the future, considering and meeting a point of fact that all entities either large or small requires a faster access to their data. For sure, it is essential that information can be made available for a broad set of audience, leading to a fact of thought that providing quick access to the data makes individuals to act upon it at a faster phase and their findings can provide a strategic benefit.
Monday, May 3, 2010
Proceeding in these lines lets have a look at the pharmaceutical industries over which the analysts specializes and bring out the market changes. This analysis from expertise gives an overview over the trends that focus over the enhancements and advantages from the pharmaceutical technology, where one can have a clarity in regard to the impacts of the emerging trends in pharma.
Pharmaceutical methodologies play a major role in the process of development of advanced medicines and also further shape the future trends of the pharma enterprises and life science industries with the increased acceptance of personalized medicine growth depending over the biological aspects of the patients.
The main focus of the pharmaceutical and biotechnology enterprises lies in streamlining its operational areas, distinctly at back end, in order to minimize its costs and time and survive along the agitated times of the market.
Pharma enterprises tend to leverage over the advanced Information Technology tools as the sales & marketing scenarios change drastically across the globe to enclose a larger array of stakeholders and market places. Lets look into few more scenarios where collaborations, market trends , tools and market strategies play a key role in the pharma domain in the later article.
Monday, February 15, 2010
Some of the challenges raised from the monitoring of real time business activities across functional departments like integrating the data as part of the clinical research into one repository in a whole, made pharmaceutical industries to focus towards Business Intelligence.
A Business Intelligence system enables effective decision support for a Pharmaceutical enterprise in which , some scenarios like the ability to integrate financial operational data with external data sources are considered. For example taking scenarios as such maintaining patient data and prescriber data from data providers, pharmacies and payers.
Cross functional data repositories with Business Intelligence is on an increasing edge wherein pharmaceutical executives tend to manage and increase their Return on Investment. Business Intelligence provides a clarity in the point of views across investments , paybacks, therapies, customer segments and brands. Business Intelligence providers along with many enterprise software vendors offers optimization of ROI.
Sunday, February 7, 2010
Clinical trials in a pharmaceutical domain can fasten its research with computerizing clinical trials and tend to manage its business in a rapid phase.
Software’s for a clinical trial makes its clinical research to be managed in a simpler way and makes it less expensive to run, gives solutions from its expertly developed features and also gives easy and resilient ways so as to maximize funds of the research.
Web based software for Clinical studies improvise the work management away from work stations. This helps the sponsor or a principle investigator to always keep in track with the latest events throughout all the phases of a study.Accessing relevant information in a timely basis helps to prevent discrepancies and loss of time.
Tuesday, July 21, 2009
Patients input their demographic, health information in their personalized health record online. This information appears in the medical record for their examination. They are provided with all the appointment details subject to the availability of slots immediately after the registration. They can directly walk in and meet their doctor in the allotted time.
- Patient Registration
- Patient Health Records
- Automated Patient Scheduling
- Automated Slot Management
- Departments, Date wise Appointments
- Appointment Alerts
- Advanced Registration Tracking
- Advanced Search Options